Event Details

KemPharm® is a rare disease therapeutics company focused on the discovery, development and commercialization of novel treatments for rare CNS and neurodegenerative diseases, lysosomal storage disorders and related treatment areas.

H.C. Wainwright Global Investment Conference

May 25, 2022 at 3:30 PM EDT